Manuela Maronati Vice President and General Manager at Italy PTC Therapeutics
Manuela is currently Vice President and General Manager Italy at PTC Therapeutics; she is responsible for managing the Italian business of PTC, a biotech company which markets Translarna, the first therapy approved to treat Duchenne Muscular Dystrophy, a rare and fatal disease that effects young children. Before this role, Manuela was the Vice President Marketing and Patient Advocacy for the EMEA Region at PTC Therapeutics, in charge of regional marketing, market access and patient advocacy strategies and tactics for the launch of Translarna. Prior to PTC, Manuela held the position of Senior Vice President Sales, Marketing and Patient Advocacy Europe at InterMune where she helped to build up the European organization from an initial nucleus of three people to 220 employees and 100 Mil € revenue when the company was sold to Roche.
In the past, Manuela has served different marketing and sales roles in Amgen Oncology both in the European Headquarters and in the UK. Manuela also set up her own start-up company Tellus that produces extra-virgin olive oil in Sardinia and export it all over Europe with the goal to improve health and quality of life of Tellus customers through the use of high quality ingredients in everyday diet. Manuela is a chartered Chemical Engineer with an MBA from Bocconi University in Italy.
EVENT DETAILS:
When: Saturday, October 7th from 10:30 – 12:30
Where: USI Auditorium, Via Buffi 13, Lugano
AGENDA:
10:15 Registration and Welcome
10:30 Introduction of the topic and guests
10:45 Manuela Maronati, Pharmaceutical Executive, Vice President of PTC Therapeutics
11:15 Stephen Norman, Senior Vice President of Peugeot
12:00 Open Panel Discussion
12:30 Standing Lunch
Come join us for this complimentary community event on Saturday, October 7th at USI!
Limited spaces, book now at emba@usi.ch